We consider that the most rigorous means of classifying MPNST is identification of biallelic NF1 alterations, which although not specific for MPNST, are considered diagnostic in the context of the relevant clinical/pathology context. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.